NSE filing, NSE: ORTINGLOBE. Summary written from the filing by ALFA Finder's alert engine.
Ortin Global Ltd: key numbers
- Share price
- ₹12.35
- Market cap
- ₹10.04 Cr
- Revenue (annual)
- ₹0.10 Cr
- Net profit (annual)
- ₹-0.74 Cr
- P/E (TTM)
- -11.1×Sector 46.5×
- Promoter holding
- 1.24%+0.01% QoQ
- FII holding
- 0.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Ortin Global Ltd
All →Ortin Global Other Announcement
Ortin Global filed its quarterly shareholding pattern for the quarter ended 30-Sep-2026 under Regulation 31(1)(b). It is a periodic disclosure with no transaction or money event.
Ortin Global Other Announcement
Ortin Global Ltd has filed the Regulation 74(5) compliance certificate from its RTA for the quarter ended September 30, 2026.
Ortin Global Annual General Meeting
Ortin Global Limited held its 39th Annual General Meeting on September 30, 2026, to discuss financial statements and director-related appointments.
Ortin Global Annual General Meeting
Ortin Global Limited has scheduled its 39th Annual General Meeting on September 30, 2026, via video conferencing. The filing also submits the company's Annual Report for FY 2025-26.
Ortin Global Management Change
Prakruti Prashant Sawant has resigned as Whole-time Director of Ortin Global Limited, effective September 7, 2026, citing professional commitments.
Ortin Global Board Meeting Outcome
Ortin Global announced management changes, including appointing a new Whole-time Director and designating a new Managing Director, alongside scheduling the 39th AGM.
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.